Stocktoria
Whitehawk Therapeutics, Inc. WHWK
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2018-06-26
Whitehawk Therapeutics, Inc. statistics & valuation
Market cap$224.3M
P / S31.4×
P / B1.6×
Net margin-288.3%
Return on equity-15.1%
FCF margin-1371.4%
Return on capital-83.9%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -1601.1% | -259.6% | -295.4% | -411.9% | -794.4% | -18.2% | — | -55.5% | — | — |
| Net margin | -288.3% | -245.1% | -270.0% | -397.7% | -786.4% | -24.8% | — | -51.6% | — | — |
| FCF margin | -1371.4% | -235.6% | -261.3% | -329.2% | -160.5% | -90.9% | — | -29.0% | — | — |
| Return on assets | -13.7% | -90.6% | -49.7% | -32.8% | -69.7% | -18.5% | -58.3% | -16.2% | -101.8% | -708.6% |
| Return on equity | -15.1% | -121.4% | -62.5% | -38.2% | -80.7% | 28.0% | 255.9% | -17.7% | -122.7% | 19.7% |
| Current ratio | 10.26 | 3.59 | 4.72 | 9.56 | 9.90 | 0.62 | 11.87 | 11.73 | 5.82 | 0.15 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.